These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 36851707)

  • 1. Short and Long-Term Cardiovascular Sequelae after SARS-CoV-2 Infection: A Narrative Review Focusing on Athletes.
    Monosilio S; Prosperi S; Squeo MR; Spataro S; Spataro A; Maestrini V
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular magnetic resonance evaluation of soldiers after recovery from symptomatic SARS-CoV-2 infection: a case-control study of cardiovascular post-acute sequelae of SARS-CoV-2 infection (CV PASC).
    Clark DE; Dendy JM; Li DL; Crum K; Dixon D; George-Durrett K; Parikh AP; Wassenaar JW; Hughes SG; Soslow JH
    J Cardiovasc Magn Reson; 2021 Oct; 23(1):106. PubMed ID: 34620179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 Cardiac Involvement in Young Competitive Athletes.
    Moulson N; Petek BJ; Drezner JA; Harmon KG; Kliethermes SA; Patel MR; Baggish AL;
    Circulation; 2021 Jul; 144(4):256-266. PubMed ID: 33866822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Clinical and Subclinical Myocarditis in Competitive Athletes With Recent SARS-CoV-2 Infection: Results From the Big Ten COVID-19 Cardiac Registry.
    Daniels CJ; Rajpal S; Greenshields JT; Rosenthal GL; Chung EH; Terrin M; Jeudy J; Mattson SE; Law IH; Borchers J; Kovacs R; Kovan J; Rifat SF; Albrecht J; Bento AI; Albers L; Bernhardt D; Day C; Hecht S; Hipskind A; Mjaanes J; Olson D; Rooks YL; Somers EC; Tong MS; Wisinski J; Womack J; Esopenko C; Kratochvil CJ; Rink LD;
    JAMA Cardiol; 2021 Sep; 6(9):1078-1087. PubMed ID: 34042947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID and Cardiovascular Disease: What We Know in 2021.
    Chilazi M; Duffy EY; Thakkar A; Michos ED
    Curr Atheroscler Rep; 2021 May; 23(7):37. PubMed ID: 33983522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of SARS-CoV-2-Associated Myocarditis in the Medical Evaluation of Athletes.
    Raukar NP; Cooper LT
    Sports Health; 2021 Mar; 13(2):145-148. PubMed ID: 33201768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low prevalence of cardiac abnormalities in competitive athletes at return-to-play after COVID-19.
    Maestrini V; Penza M; Filomena D; Birtolo LI; Monosilio S; Lemme E; Squeo MR; Mango R; Di Gioia G; Serdoz A; Fiore R; Fedele F; Pelliccia A; Di Giacinto B
    J Sci Med Sport; 2023 Jan; 26(1):8-13. PubMed ID: 36372623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-COVID-19 Cardiovascular Sequelae and Myocarditis.
    Yarlagadda LC; Ghosh D; Basak U; Senapati M; Das M; Ghosh R
    J Assoc Physicians India; 2023 Jun; 71(6):11-12. PubMed ID: 37355846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pericardial and myocardial involvement after SARS-CoV-2 infection: a cross-sectional descriptive study in healthcare workers.
    Eiros R; Barreiro-Pérez M; Martín-García A; Almeida J; Villacorta E; Pérez-Pons A; Merchán S; Torres-Valle A; Sánchez-Pablo C; González-Calle D; Pérez-Escurza O; Toranzo I; Díaz-Peláez E; Fuentes-Herrero B; Macías-Álvarez L; Oliva-Ariza G; Lecrevisse Q; Fluxa R; Bravo-Grande JL; Orfao A; Sánchez PL;
    Rev Esp Cardiol (Engl Ed); 2022 Sep; 75(9):734-746. PubMed ID: 34866030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond Acute COVID-19: A Review of Long-term Cardiovascular Outcomes.
    Parhizgar P; Yazdankhah N; Rzepka AM; Chung KYC; Ali I; Lai Fat Fur R; Russell V; Cheung AM
    Can J Cardiol; 2023 Jun; 39(6):726-740. PubMed ID: 36754119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review on Cardiorespiratory Complications after SARS-CoV-2 Infection in Young Adult Healthy Athletes.
    Romagnoli S; Sbrollini A; Marcantoni I; Morettini M; Burattini L
    Int J Environ Res Public Health; 2022 May; 19(9):. PubMed ID: 35565074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term cardiac follow-up of athletes infected with SARS-CoV-2 after resumption of elite-level sports.
    van Hattum JC; Daems JJN; Verwijs SM; Wismans LV; van Diepen MA; Groenink M; Boekholdt SM; Planken RN; van Randen A; Hirsch A; Moen MH; Pinto YM; Wilde AAM; Jørstad HT
    Heart; 2024 Jan; 110(4):254-262. PubMed ID: 37678891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study on the consequences of SARS-CoV-2 infection on the heart of young adult competitive athletes: Implications for a safe return-to-play.
    Cavigli L; Frascaro F; Turchini F; Mochi N; Sarto P; Bianchi S; Parri A; Carraro N; Valente S; Focardi M; Cameli M; Bonifazi M; D'Ascenzi F
    Int J Cardiol; 2021 Aug; 336():130-136. PubMed ID: 34082008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular Magnetic Resonance for Patients With COVID-19.
    Petersen SE; Friedrich MG; Leiner T; Elias MD; Ferreira VM; Fenski M; Flamm SD; Fogel M; Garg R; Halushka MK; Hays AG; Kawel-Boehm N; Kramer CM; Nagel E; Ntusi NAB; Ostenfeld E; Pennell DJ; Raisi-Estabragh Z; Reeder SB; Rochitte CE; Starekova J; Suchá D; Tao Q; Schulz-Menger J; Bluemke DA
    JACC Cardiovasc Imaging; 2022 Apr; 15(4):685-699. PubMed ID: 34656482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosing COVID-19 myocarditis in athletes using cMRI.
    Patel P; Thompson PD
    Trends Cardiovasc Med; 2022 Apr; 32(3):146-150. PubMed ID: 34954013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiopulmonary examinations of athletes returning to high-intensity sport activity following SARS-CoV-2 infection.
    Babity M; Zamodics M; Konig A; Kiss AR; Horvath M; Gregor Z; Rakoczi R; Kovacs E; Fabian A; Tokodi M; Sydo N; Csulak E; Juhasz V; Lakatos BK; Vago H; Kovacs A; Merkely B; Kiss O
    Sci Rep; 2022 Dec; 12(1):21686. PubMed ID: 36522351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catecholamines Are the Key Trigger of COVID-19 mRNA Vaccine-Induced Myocarditis: A Compelling Hypothesis Supported by Epidemiological, Anatomopathological, Molecular, and Physiological Findings.
    Cadegiani FA
    Cureus; 2022 Aug; 14(8):e27883. PubMed ID: 35971401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Findings From Cardiovascular Evaluation of National Collegiate Athletic Association Division I Collegiate Student-Athletes After Asymptomatic or Mildly Symptomatic SARS-CoV-2 Infection.
    Hwang CE; Kussman A; Christle JW; Froelicher V; Wheeler MT; Moneghetti KJ
    Clin J Sport Med; 2022 Mar; 32(2):103-107. PubMed ID: 34173780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocarditis Screening Methods in Athletes After SARS-CoV-2 Infection - a Systematic Review.
    Hofbauer T; Humann K; Neidenbach RC; Scharhag J
    Int J Sports Med; 2023 Dec; 44(13):929-940. PubMed ID: 37225132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.